AMH and polycystic ovary syndrome: Defined study and control populations, biologically relevant cutoff values that reflect clustering of clinical features and are relevant to health outcomes and age-specific and improved accuracy and standardization of AMH assays are necessary before introducing AMH values as a diagnostic marker for PCOS (53).